Abingdon Health (#ABDX) – “up to” £0.200m ‘retail offer’ raises £0.177m at 6p per share

Abingdon Health (#ABDX) – H1 increased loss, board reshuffling

Abingdon Health (#ABDX) – “retail offer” raises £0.4m at 9.75p per share

Abingdon Health (#ABDX) – cash down to £1.3m at end-June, states latest quarter “cashflow positive”

Testing! Testing! Testing! This Medical Pioneer's Tests Are Selling Well.

Hello Share Razzlers. My penny share tip this time is a York University company that does rapid medical tests, including for pregnancy. Abingdon Health (ABDX) shares are currently around 11p, but deserves better, methinks.

Abingdon Health (#ABDX) – acquisition of regulatory consultancy support business IVDeology for up to £0.7m in shares

Abingdon Health (#ABDX) – AGM update, “confident… sufficient cash resources to fund progress beyond the next 12 months”. Then what?

Abingdon Health – full-year results argue “well placed”. Er, what about the cash burn?!

Describing itself as “a leading international developer and manufacturer of high quality, rapid diagnostic tests”, Abingdon Health (ABDX) has announced results for its year ended 30th June 2022 with CEO Chris Yates arguing “as a knowledge leader in lateral flow, and with our comprehensive contract service offering, we believe we are well-placed to support customers in bringing their products to market and grow our business”. So why are the shares currently 12.5% lower today to 5.25p?

Abingdon Health (#ABDX) – notes judgement in favour of the DHSC including lack of state aid to company

Abingdon Health (#ABDX) – notes a judgement in Judicial Review initiated by Good Law Project against Department of Health & Social Care expected today at 12noon

Abingdon Health – even more bad news, ouzo on my cornflakes

I warned before it listed that Abingdon Health (ABDX) was essentially insolvent and that the 96p ( £92 million market cap) was bonkers and that anyone investing was insane.  But, of course, institutional fund managers (playing with YOUR  money) knew better and gambled £22 million. After the latest shocking news the shares are, after 19 months, just 6.75p. Ouch.

Abingdon Health (#ABDX) – FY “substantial loss”, further contract problem, NED Lyn Rees to leave

Abingdon Health (#ABDX) – H1 revenue collapse to £1.7m, cash down to £5.9m

Abingdon sings at the Covid bailout placing ball, next up Omega Diagnostics then Abingdon again?

Abingdon Health (ABDX) will, no doubt, claim that its up to £6 million placing, open offer and Primary Bid offer at 25p is down solely to the DHSC not paying delayed bills. But then again this was a company that was technically insolvent before it raised £20 million at is IPO a year ago so, in my view, it has always been a basket case and I have explicitly warned you many times that a bailout was looming. For the record, this will not be the last one. So, who is next? Abingdon again or the other grossly overhyped covid dog Omega (OMX). But first a covid prediction…

Abingdon Health (#ABDX) – minimum £4m placing, £1m open offer & £0.5m PrimaryBid offer at just 25p per share

Abingdon Health after the corrupt deadwood press pump when’s the placing dump?

I should have mentioned this in bearcast yesterday, the maths is clear and unchallengeable. Abingdon Health (ABDX), a company I warned you about at IPO as it was insolvent and the valuation absurd, is pumping its stock via the yellow journalists on the Daily Mail and the Telegraph ahead of a bailout placing. You know the score: mug punters overpay in the secondary market ahead of a placing at a vast discount to fund managers.

Abingdon Health – “BioSURE COVID-19 IgG Antibody Self Test” share price rise justified?

A “Launch of BioSURE COVID-19 IgG Antibody Self Test”-titled announcement from Abingdon Health (ABDX) – and the shares currently up nearly 50%, to 45.5p, in response. Does this look justified?...

Abingdon Health – Tom having warned on IPO only in December, ANOTHER ‘trading update’ calamity

Well done to the Sheriff of AIM for calling this IPO out as a dog with fleas from the outset. A trading update for its year ended 30th June 2021 from Abingdon Health (ABDX) includes trading performance “in line with the guidance given in April 2021. As at 30 June 2021 the company had net cash of £4.9m”. So why are the shares currently 19% further lower to 30p?

Abingdon Health (#ABDX) – FY update, notes “pressure on cash flow” from DHSC Judicial Review